Published in J Neurosci Methods on May 01, 1983
Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury. J Clin Invest (2002) 3.08
Evaluation of the hematoma consequences, neurobehavioral profiles, and histopathology in a rat model of pontine hemorrhage. J Neurosurg (2012) 2.02
Chemokine expression during hepatic ischemia/reperfusion-induced lung injury in the rat. The role of epithelial neutrophil activating protein. J Clin Invest (1995) 1.67
Evidence of compromised blood-spinal cord barrier in early and late symptomatic SOD1 mice modeling ALS. PLoS One (2007) 1.58
Hypothermic circulatory arrest increases permeability of the blood brain barrier in watershed areas. Ann Thorac Surg (2010) 1.55
Intravital multiphoton imaging of immune responses in the mouse ear skin. Nat Protoc (2012) 1.35
Genetic evidence for a noncanonical function of seryl-tRNA synthetase in vascular development. Circ Res (2009) 1.23
Novel critical role of Toll-like receptor 4 in lung ischemia-reperfusion injury and edema. Am J Physiol Lung Cell Mol Physiol (2009) 1.15
Blood-brain barrier changes and cell invasion differ between therapeutic immune clearance of neurotrophic virus and CNS autoimmunity. Proc Natl Acad Sci U S A (2008) 1.14
Role of PAF receptors during intestinal ischemia and reperfusion injury. A comparative study between PAF receptor-deficient mice and PAF receptor antagonist treatment. Br J Pharmacol (2003) 1.10
Inflammation and enhanced nociceptive responses to bladder distension produced by intravesical zymosan in the rat. BMC Urol (2006) 1.07
Post-junctional facilitation of Substance P signaling in a tibia fracture rat model of complex regional pain syndrome type I. Pain (2009) 1.05
Mycoplasma pulmonis infections cause long-lasting potentiation of neurogenic inflammation in the respiratory tract of the rat. J Clin Invest (1991) 1.05
Characterization of the capsaicin-sensitive component of cyclophosphamide-induced inflammation in the rat urinary bladder. Br J Pharmacol (1994) 1.04
Characterization of vascular disruption and blood-spinal cord barrier permeability following traumatic spinal cord injury. J Neurotrauma (2014) 1.04
The neuraminidase inhibitor oseltamivir is effective against A/Anhui/1/2013 (H7N9) influenza virus in a mouse model of acute respiratory distress syndrome. J Infect Dis (2013) 1.03
Neurogenic plasma leakage in mouse airways. Br J Pharmacol (1999) 1.03
Effect of a Paf antagonist, WEB 2086, on airway microvascular leakage in the guinea-pig and platelet aggregation in man. Br J Pharmacol (1988) 1.02
Arginine-vasopressin V1a receptor inhibition improves neurologic outcomes following an intracerebral hemorrhagic brain injury. Neurochem Int (2011) 1.02
Distinct patterns of cerebral extravasation by Evans blue and sodium fluorescein in rats. PLoS One (2013) 1.00
Substance P mediates inflammatory oedema in acute pancreatitis via activation of the neurokinin-1 receptor in rats and mice. Br J Pharmacol (2000) 0.98
Effects of the bradykinin antagonist, HOE 140, in experimental acute pancreatitis. Br J Pharmacol (1992) 0.98
Enterococcus faecalis overcomes foreign body-mediated inflammation to establish urinary tract infections. Infect Immun (2012) 0.98
Multicolor fluorescence imaging of traumatic brain injury in a cryolesion mouse model. ACS Chem Neurosci (2012) 0.97
CXCR2 is critical for dsRNA-induced lung injury: relevance to viral lung infection. J Inflamm (Lond) (2005) 0.96
A model of DENV-3 infection that recapitulates severe disease and highlights the importance of IFN-γ in host resistance to infection. PLoS Negl Trop Dis (2012) 0.94
Pathological events in experimental acute pancreatitis prevented by the bradykinin antagonist, Hoe 140. Br J Pharmacol (1993) 0.94
Hyperresponsiveness to inhaled but not intravenous methacholine during acute respiratory syncytial virus infection in mice. Respir Res (2005) 0.94
Characterization of the brain injury, neurobehavioral profiles, and histopathology in a rat model of cerebellar hemorrhage. Exp Neurol (2010) 0.93
Thrombin inhibits NMDA-mediated nociceptive activity in the mouse: possible mediation by endothelin. J Physiol (2003) 0.89
Calcium supplementation during sepsis exacerbates organ failure and mortality via calcium/calmodulin-dependent protein kinase kinase signaling. Crit Care Med (2013) 0.89
BMP signaling through BMPRIA in astrocytes is essential for proper cerebral angiogenesis and formation of the blood-brain-barrier. Mol Cell Neurosci (2008) 0.88
Optimization of Evans blue quantitation in limited rat tissue samples. Sci Rep (2014) 0.88
Beneficial effects of estrogen in a mouse model of cerebrovascular insufficiency. PLoS One (2009) 0.87
Nitric Oxide Protects against Infection-Induced Neuroinflammation by Preserving the Stability of the Blood-Brain Barrier. PLoS Pathog (2016) 0.87
Evans blue staining reveals vascular leakage associated with focal areas of host-parasite interaction in brains of pigs infected with Taenia solium. PLoS One (2014) 0.86
Tau depletion prevents progressive blood-brain barrier damage in a mouse model of tauopathy. Acta Neuropathol Commun (2015) 0.85
Role of tachykinin NK receptors on the local and remote injuries following ischaemia and reperfusion of the superior mesenteric artery in the rat. Br J Pharmacol (2002) 0.84
Involvement of tissue kallikrein but not plasma kallikrein in the development of symptoms mediated by endogenous kinins in acute pancreatitis in rats. Br J Pharmacol (2002) 0.84
Uptake of 18F-fluorocholine, 18F-fluoro-ethyl-L: -tyrosine and 18F-fluoro-2-deoxyglucose in F98 gliomas in the rat. Eur J Nucl Med Mol Imaging (2006) 0.84
Evaluation of laser speckle contrast imaging as an intrinsic method to monitor blood brain barrier integrity. Biomed Opt Express (2013) 0.84
Visualizing leukocyte trafficking in the living brain with 2-photon intravital microscopy. Front Cell Neurosci (2013) 0.83
Barrier effect of Esoxx(®) on esophageal mucosal damage: experimental study on ex-vivo swine model. Clin Exp Gastroenterol (2012) 0.83
CNS-targeted production of IL-17A induces glial activation, microvascular pathology and enhances the neuroinflammatory response to systemic endotoxemia. PLoS One (2013) 0.82
Polynitroxylated starch/TPL attenuates cachexia and increased epithelial permeability associated with TNBS colitis. Inflammation (2002) 0.82
Vascular endothelial growth factor mediates the estrogen-induced breakdown of tight junctions between and increase in proliferation of microvessel endothelial cells in the baboon endometrium. Endocrinology (2008) 0.81
Platelet activating factor and systemic anaphylaxis in Nippostrongylus brasiliensis-sensitized rats: differential effects of PAF antagonists. Br J Pharmacol (1992) 0.79
Changes in the blood-nerve barrier after sciatic nerve cold injury: indications supporting early treatment. Neural Regen Res (2015) 0.78
Role of histamine in brain protection in surgical brain injury in mice. Brain Res (2008) 0.77
Attenuated plasma extravasation to sensory neuropeptides in diabetic rats. Agents Actions (1993) 0.77
Upregulation of vascular endothelial growth factor receptor-3 in the spinal cord of Lewis rats with experimental autoimmune encephalomyelitis. J Histochem Cytochem (2012) 0.77
Subversion of early innate antiviral responses during antibody-dependent enhancement of Dengue virus infection induces severe disease in immunocompetent mice. Med Microbiol Immunol (2014) 0.76
Sample-free quantification of blood biomarkers via laser-treated skin. Biomaterials (2015) 0.76
Pretreatment with Evans blue, a stimulator of BK(Ca) channels, inhibits compound 48/80-induced shock, systemic inflammation, and mast cell degranulation in the rat. Histochem Cell Biol (2015) 0.76
Novel molecular "add-on" based on Evans Blue confers superior pharmacokinetics and transforms drugs to theranostic agents. J Nucl Med (2016) 0.75
Recombinant or plasma-derived antisecretory factor inhibits cholera toxin-induced increase in Evans blue permeation of rat intestinal capillaries. Dig Dis Sci (1998) 0.75
The postpartum period of pregnancy worsens brain injury and functional outcome after cerebellar hemorrhage in rats. Acta Neurochir Suppl (2011) 0.75
Dasatinib inhibits actin fiber reorganization and promotes endothelial cell permeability through RhoA-ROCK pathway. Cancer Med (2017) 0.75
The effect of bronchial blood flow on hyperpnea-induced airway obstruction and injury. J Clin Invest (1995) 0.75
Microangiopathy triggers, and inducible nitric oxide synthase exacerbates dextran sulfate sodium-induced colitis. Lab Invest (2015) 0.75
Peptidergic neurones. Nature (1980) 3.36
Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J (1993) 3.29
Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. Acta Physiol Scand (1982) 3.25
Greatly increased luminal nitric oxide in ulcerative colitis. Lancet (1994) 2.96
A substance P antagonist inhibits vagally induced increase in vascular permeability and bronchial smooth muscle contraction in the guinea pig. Proc Natl Acad Sci U S A (1983) 2.64
Capsaicin-induced desensitization of airway mucosa to cigarette smoke, mechanical and chemical irritants. Nature (1983) 2.57
Intragastric nitric oxide production in humans: measurements in expelled air. Gut (1994) 2.53
Pancreatic polypeptide family (APP, BPP, NPY and PYY) in relation to sympathetic vasoconstriction resistant to alpha-adrenoceptor blockade. Acta Physiol Scand (1982) 2.23
Substance P-immunoreactive sensory nerves in the lower respiratory tract of various mammals including man. Cell Tissue Res (1984) 2.05
Enkephalin-like immunoreactivity in gland cells and nerve terminals of the adrenal medulla. Neuroscience (1978) 2.01
Vasoactive intestinal polypeptide in cholinergic neurons of exocrine glands: functional significance of coexisting transmitters for vasodilation and secretion. Proc Natl Acad Sci U S A (1980) 2.00
Long-term pharmacokinetics of clozapine. Br J Psychiatry (1998) 1.97
Co-existence of substance P and calcitonin gene-related peptide-like immunoreactivities in sensory nerves in relation to cardiovascular and bronchoconstrictor effects of capsaicin. Eur J Pharmacol (1985) 1.97
Localization of peptide YY (PYY) in gastrointestinal endocrine cells and effects on intestinal blood flow and motility. Proc Natl Acad Sci U S A (1982) 1.95
High nitric oxide production in human paranasal sinuses. Nat Med (1995) 1.90
Vascular protein linkage in various tissue induced by substance P, capsaicin, bradykinin, serotonin, histamine and by antigen challenge. Naunyn Schmiedebergs Arch Pharmacol (1983) 1.85
Release of multiple tachykinins from capsaicin-sensitive sensory nerves in the lung by bradykinin, histamine, dimethylphenyl piperazinium, and vagal nerve stimulation. Am Rev Respir Dis (1988) 1.84
Polypeptide-containing neurons in airway smooth muscle. Annu Rev Physiol (1987) 1.70
Primarily nasal origin of exhaled nitric oxide and absence in Kartagener's syndrome. Eur Respir J (1994) 1.69
High levels of neuropeptide Y in peripheral noradrenergic neurons in various mammals including man. Neurosci Lett (1983) 1.68
Evidence for coexistence of vasoactive intestinal polypeptide (VIP) and acetylcholine in neurons of cat exocrine glands. Morphological, biochemical and functional studies. Acta Physiol Scand Suppl (1981) 1.64
A galanin-like peptide in the central nervous system and intestine of the rat. Neurosci Lett (1984) 1.63
Capsaicin-sensitive vagal neurons involved in control of vascular permeability in rat trachea. Acta Physiol Scand (1982) 1.59
Substance P and capsaicin-induced contraction of human bronchi. Acta Physiol Scand (1983) 1.59
Pulmonary chemoreflexes elicited by intravenous injection of lactic acid in anesthetized rats. J Appl Physiol (1985) (1996) 1.58
Release of histamine by substance P. Naunyn Schmiedebergs Arch Pharmacol (1981) 1.56
Potentiation of tachykinin-induced plasma protein extravasation by calcitonin gene-related peptide. Eur J Pharmacol (1985) 1.56
Plasma CGRP in acute myocardial infarction. Lancet (1990) 1.55
Co-existence of peptide HI (PHI) and VIP in nerves regulating blood flow and bronchial smooth muscle tone in various mammals including man. Peptides (1984) 1.51
Effects and distribution of vagal capsaicin-sensitive substance P neurons with special reference to the trachea and lungs. Acta Physiol Scand (1983) 1.51
Neuropeptide Y (NPY) depresses the secretion of 3H-noradrenaline and the contractile response evoked by field stimulation, in rat vas deferens. Acta Physiol Scand (1984) 1.45
Peptide neurons in the vagus, splanchnic and sciatic nerves. Acta Physiol Scand (1978) 1.42
Bronchial smooth muscle contraction induced by stimulation of capsaicin-sensitive sensory neurons. Acta Physiol Scand (1982) 1.41
Calcitonin gene-related peptide (CGRP) in capsaicin-sensitive substance P-immunoreactive sensory neurons in animals and man: distribution and release by capsaicin. Peptides (1987) 1.41
Ultrastructural localization of VIP-like immunoreactivity in large dense-core vesicles of 'cholinergic-type' nerve terminals in cat exocrine glands. Neuroscience (1981) 1.41
Cardiac outflow of endothelin, neuropeptide Y and noradrenaline in relation to hyperaemia in coronary sinus flow following electrical conversion of induced ventricular fibrillation in man. Eur Heart J (1995) 1.40
Cigarette smoke-induced airway oedema due to activation of capsaicin-sensitive vagal afferents and substance P release. Neuroscience (1983) 1.40
Involvement of 5-hydroxytryptamine, prostaglandin E2, and cyclic adenosine monophosphate in cholera toxin-induced fluid secretion in the small intestine of the rat in vivo. Gastroenterology (1989) 1.39
Induction of tachykinin gene and peptide expression in guinea pig nodose primary afferent neurons by allergic airway inflammation. J Clin Invest (1996) 1.38
Frequency- and reserpine-dependent chemical coding of sympathetic transmission: differential release of noradrenaline and neuropeptide Y from pig spleen. Neurosci Lett (1986) 1.38
Vascular permeability changes and smooth muscle contraction in relation to capsaicin-sensitive substance P afferents in the guinea-pig. Acta Physiol Scand (1984) 1.38
Multiple tachykinins (neurokinin A, neuropeptide K and substance P) in capsaicin-sensitive sensory neurons in the guinea-pig. Regul Pept (1985) 1.35
Vanilloid (capsaicin) receptors in the rat: distribution in the brain, regional differences in the spinal cord, axonal transport to the periphery, and depletion by systemic vanilloid treatment. Brain Res (1995) 1.32
Sensory neurons mediate protective vasodilatation in rat gastric mucosa. Am J Physiol (1991) 1.31
Cough and bronchoconstriction mediated by capsaicin-sensitive sensory neurons in the guinea-pig. Pulm Pharmacol (1988) 1.30
Neuropeptide Y receptor in pig spleen: binding characteristics, reduction of cyclic AMP formation and calcium antagonist inhibition of vasoconstriction. Eur J Pharmacol (1988) 1.28
Baroreflex modulation of sympathetic activity and sympathetic neurotransmitters in humans. Acta Physiol Scand (1988) 1.27
Enkephalin immunoreactive nerve fibres and cell bodies in sympathetic ganglia of the guinea-pig and rat. Neuroscience (1979) 1.26
Enkephalin- and somatostatin-like immunoreactivities in human adrenal medulla and pheochromocytoma. Proc Natl Acad Sci U S A (1979) 1.26
Enkephalin-like immunoreactivity in nerve terminals in sympathetic ganglia and adrenal medulla and in adrenal medullary gland cells. Acta Physiol Scand (1978) 1.26
Calcitonin gene-related peptide and its binding sites in the human central nervous system and pituitary. Proc Natl Acad Sci U S A (1985) 1.24
Occurrence of vasoactive intestinal polypeptide (VIP)-like immunoreactivity in certain cholinergic neurons of the cat: evidence from combined immunohistochemistry and acetylcholinesterase staining. Neuroscience (1979) 1.23
Neuropeptide Y--a cotransmitter with noradrenaline and adenosine 5'-triphosphate in the sympathetic nerves of the mouse vas deferens? A biochemical, physiological and electropharmacological study. Neuroscience (1986) 1.22
Simultaneous release of several tachykinins and calcitonin gene-related peptide from rat spinal cord slices. Neurosci Lett (1986) 1.19
Immunohistochemical evidence for a local VIP-ergic neuron system in the adrenal gland of the rat. Acta Physiol Scand (1981) 1.19
Substance P-, VIP-, and enkephalin-like immunoreactivity in the human vagus nerve. Gastroenterology (1979) 1.19
Effects of neuropeptide Y (NPY) on mechanical activity and neurotransmission in the heart, vas deferens and urinary bladder of the guinea-pig. Acta Physiol Scand (1984) 1.18
Differential release of calcitonin gene-related peptide and neuropeptide Y from the isolated heart by capsaicin, ischaemia, nicotine, bradykinin and ouabain. Acta Physiol Scand (1989) 1.17
Calcitonin gene-related peptide (CGRP) and capsaicin-induced stimulation of heart contractile rate and force. Naunyn Schmiedebergs Arch Pharmacol (1985) 1.15
Comparison of cardiovascular and bronchoconstrictor effects of substance P, substance K and other tachykinins. Naunyn Schmiedebergs Arch Pharmacol (1984) 1.14
Guanethidine-sensitive release of neuropeptide Y-like immunoreactivity in the cat spleen by sympathetic nerve stimulation. Neurosci Lett (1984) 1.14
Leukotrienes C4, D4 and E4 cause widespread and extensive plasma extravasation in the guinea pig. Naunyn Schmiedebergs Arch Pharmacol (1985) 1.14
Multiple co-existence of peptides and classical transmitters in peripheral autonomic and sensory neurons--functional and pharmacological implications. Prog Brain Res (1986) 1.14
Capsaicin and nicotine-sensitive afferent neurones and nasal secretion in healthy human volunteers and in patients with vasomotor rhinitis. Br J Pharmacol (1989) 1.13
Coexistence of an avian pancreatic polypeptide (APP) immunoreactive substance and catecholamine in some peripheral and central neurons. Acta Physiol Scand (1980) 1.13
Origin of peptide-containing fibers in the inferior mesenteric ganglion of the guinea-pig: immunohistochemical studies with antisera to substance P, enkephalin, vasoactive intestinal polypeptide, cholecystokinin and bombesin. Neuroscience (1983) 1.13
Elevated plasma endothelin-1 concentrations are associated with the severity of illness in patients with sepsis. Ann Surg (1991) 1.12
Radioimmunoassay for neuropeptide Y (NPY): chromatographic characterization of immunoreactivity in plasma and tissue extracts. Scand J Clin Lab Invest (1985) 1.12
Specific receptor and cardiovascular effects of calcitonin gene-related peptide. Endocrinology (1986) 1.11
Vasoactive intestinal polypeptide and cholinergic mechanisms in cat nasal mucosa: studies on choline acetyltransferase and release of vasoactive intestinal polypeptide. Proc Natl Acad Sci U S A (1981) 1.11
Videotape preparation of patients before hip replacement surgery reduces stress. Psychosom Med (2000) 1.09
Cellular and subcellular localization of protein I in the peripheral nervous system. Proc Natl Acad Sci U S A (1982) 1.09
Cardiovascular effects of calcitonin gene-related peptides I and II in man. Circ Res (1987) 1.08
Immunocytochemical identification of polypeptide YY (PYY) cells in the human gastrointestinal tract. Histochemistry (1983) 1.08
Distribution and origin of substance P- and neuropeptide Y-immunoreactive nerves in the guinea-pig heart. Cell Tissue Res (1986) 1.08
Peripheral effects of opioid drugs on capsaicin-sensitive neurones of the guinea-pig bronchus and rabbit ear. Naunyn Schmiedebergs Arch Pharmacol (1987) 1.08
Origin and distribution of capsaicin-sensitive substance P-immunoreactive nerves in the nasal mucosa. Acta Otolaryngol (1983) 1.08
Neuropeptide Y (NPY)- and FMRFamide neuropeptide-like immunoreactivities in catecholamine neurons of the rat medulla oblongata. Acta Physiol Scand (1983) 1.08
Dose-related plasma levels of clozapine: influence of smoking behaviour, sex and age. Psychopharmacology (Berl) (1989) 1.08
Effects of the bradykinin antagonist B4310 on smooth muscles and blood pressure in the rat, and its enzymatic degradation. Br J Pharmacol (1989) 1.07
Immunohistochemical studies on the effect of capsaicin on spinal and medullary peptide and monoamine neurons using antisera to substance P, gastrin/CCK, somatostatin, VIP, enkephalin, neurotensin and 5-hydroxytryptamine. J Neurocytol (1981) 1.07
Mechanisms underlying pre- and postjunctional effects of neuropeptide Y in sympathetic vascular control. Acta Physiol Scand (1986) 1.06
Neuropeptide Y-, substance P- and VIP-immunoreactive nerves in cat spleen in relation to autonomic vascular and volume control. Cell Tissue Res (1985) 1.05
Immunoreactive calcitonin gene-related peptide and substance P coexist in sensory neurons to the spinal cord and interact in spinal behavioral responses of the rat. Neurosci Lett (1984) 1.04
Intravenous drug injection habits: drug users' self-reports versus researchers' perception. Pharmacology (2003) 1.04